[HTML][HTML] Comparing the Serum Level of Vascular Endothelial Growth Factor (VEGF) in Patients with Active Pulmonary Tuberculosis and the Control Group: A Case …

A Nemati, R Alavi Naeini, E Moosapoor… - Iranian South Medical …, 2023 - ismj.bpums.ac.ir
Background: Angiogenesis is seen in active pulmonary tuberculosis. One of the factors
involved in angiogenesis is vascular endothelial growth factor (VEGF). Therefore, the aim of …

[HTML][HTML] Molecular detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from lorestan province, Iran from 2014 to 2017

F Heidary, HE Lashgarian, M Karkhane… - Archives of Clinical …, 2020 - brieflands.com
Background: A rise in multidrug-resistant tuberculosis (MDR-TB), which is defined as the
resistance to the two most effective first-line therapeutic drugs, Isoniazid (INH) and Rifampin …

[HTML][HTML] Prevalence of Antibiotic Resistance to Isonicotinylhydrazide and Rifampicin in Culture Positive Pulmonary Tuberculosis Patients from 2014 to 2016 in …

SM Hashemi Shahri, F Fardoust… - Hospital Practices and …, 2019 - jhpr.ir
Background: One third of the world's population is infected with TB, and the disease is
known as the second deadly global infection, even more severe than measles. The disease …

MolecularDetectionof IsoniazidandRifampinResistancein MycobacteriumtuberculosisIsolatesfromLorestanProvince, Iranfrom

F Heidary, H EsmaeilLashgarian, M Karkhane… - Arch Clin Infect …, 2019 - eprints.lums.ac.ir
Background: A rise in multidrug-resistant tuberculosis (MDR-TB), which is defined as the
resistance to the two most effective firstline therapeutic drugs, Isoniazid (INH) and Rifampin …